Advertisement
Singapore markets open in 6 hours 16 minutes
  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     
  • S&P 500

    5,075.71
    +65.11 (+1.30%)
     
  • Dow

    38,526.66
    +286.68 (+0.75%)
     
  • Nasdaq

    15,728.52
    +277.22 (+1.79%)
     
  • Bitcoin USD

    66,659.15
    +196.90 (+0.30%)
     
  • CMC Crypto 200

    1,437.02
    +22.26 (+1.57%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Gold

    2,339.10
    -7.30 (-0.31%)
     
  • Crude Oil

    83.33
    +1.43 (+1.75%)
     
  • 10-Yr Bond

    4.5960
    -0.0270 (-0.58%)
     
  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     
  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     
  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Univar (UNVR) & Angus Expand Distribution Deal in Europe

Univar Solutions Inc.’s UNVR subsidiary, Europe, Univar B.V. announced the expansion of its distribution agreement with Angus Chemical Company. The latter is a leading global manufacturer of specialty chemicals for life sciences, home and personal care and industrial markets. The deal has been expanded to include the pan-European Homecare & Industrial Cleaning (HIC) market.

This agreement will facilitate Univar to provide its customers with extended access to specialty cleaning ingredients and comprehensive technical innovation and sourcing support.

Per the deal, Univar customers across Europe will now have access to Angus' specialty additives, which are geared to improve cleaning products’ performance, safety profile and stability, even in the most demanding applications.

The deal broadens Univar’s relationship with Angus, which currently serves customers in the Beauty & Personal Care and Coatings, Adhesives, Sealants & Elastomers and Rubber & Plastic Additives markets. Angus’ unique portfolio of globally registered amino alcohol additives meets complex HIC formulating requirements and complements Univar’s wide specialty ingredients and solutions offering.

ADVERTISEMENT

Shares of Univar have gained 9% in the past year against a 9.1% decline of the industry.

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

In its last earnings call, the company stated that it expects adjusted EBITDA for second-quarter 2022 to be $270-$290 million. For 2022, adjusted EBITDA is forecast in the band of $1,000-$1,050 million. The guidance considers anticipated continued strong business conditions, market share growth and benefits from Nexeo net synergies. The company also sees net free cash flow for 2022 in the range of $400-$450 million.

Univar Solutions Inc. Price and Consensus

 

Univar Solutions Inc. Price and Consensus
Univar Solutions Inc. Price and Consensus

Univar Solutions Inc. price-consensus-chart | Univar Solutions Inc. Quote

 

Zacks Rank & Other Key Picks

Univar currently sports a Zacks Rank #1 (Strong Buy).

Some other top-ranked stocks in the basic materials space are Allegheny Technologies Inc. ATI, Nutrien Ltd. NTR and Cabot Corporation CBT.

Allegheny has a projected earnings growth rate of 869.2% for the current year. The Zacks Consensus Estimate for ATI's current-year earnings has been revised 27.3% upward in the past 60 days.

Allegheny’s earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 128.9%, on average. ATI has gained around 6.5% in a year and currently sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Nutrien has a projected earnings growth rate of 161.9% for the current year. The Zacks Consensus Estimate for NTR’s current-year earnings has been revised 26.9% upward in the past 60 days.

Nutrien’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, the average being 5.8%. NTR has gained 59.5% in a year. The company flaunts a Zacks Rank #1.

Cabot, currently carrying a Zacks Rank #2, has an expected earnings growth rate of 21.5% for the current year. The Zacks Consensus Estimate for CBT's earnings for the current year has been revised 5.2% upward in the past 60 days.

Cabot’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 16.2%. CBT has gained around 11.6% over a year.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Allegheny Technologies Incorporated (ATI) : Free Stock Analysis Report
 
Cabot Corporation (CBT) : Free Stock Analysis Report
 
Univar Solutions Inc. (UNVR) : Free Stock Analysis Report
 
Nutrien Ltd. (NTR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research